Radioiodination of cyclin dependent kinase inhibitor Olomoucine loaded Fe@ Au nanoparticle and evaluation of the therapeutic efficacy on cancerous cells


TAKAN G., Guldu O. K. , MEDİNE E. İ.

RADIOCHIMICA ACTA, cilt.105, ss.225-240, 2017 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 105 Konu: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1515/ract-2016-2629
  • Dergi Adı: RADIOCHIMICA ACTA
  • Sayfa Sayısı: ss.225-240

Özet

Magnetic nanoparticles have promising biomedical applications such as drug delivery, novel therapeutics and diagnostic imaging. Magnetic drug delivery combination works on the delivery of magnetic nanoparticles loaded with drug to the target tissue by means of an external magnetic field. Gold coated iron oxide (Fe@ Au) nanoparticles can provide useful surface chemistry and biological reactivity. Covalent conjugation to the Fe@ Au nanoparticles through cleavable linkages can be used to deliver drugs to tumor cells, then the drug can be released by an external. In this paper, purine based cyclin dependent kinases (CDKs) inhibitor Olomoucine (Olo) [2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine] was loaded on gold coated iron oxide (Fe@ Au) nanoparticles and radiolabeled with I-131 to combine magnetic targeted drug delivery and radiotherapy. Fe@ Au nanoparticles were synthesized by microemulsion method. The characterization of nanoparticles was examined by TEM, VSM and XRD. Amine activation was utilized by cysteamine hydrochloride and then CDI was used for conjugation of Olomoucine. Antiproliferative effect and cytotoxicity of Olomoucine loaded Fe@ Au nanoparticles (Fe@ Au-Olo) were investigated on MCF7 and A549 cell lines. Proliferation rate was decreased while uptake of Fe@ Au-Olo on both cell lines was high in comparison with Olomoucine. Also, enhanced incorporation ratio was observed under external magnetic field.